We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Wearable AI Tool Predicts Hospitalization Risk in Heart Failure

By HospiMedica International staff writers
Posted on 12 Apr 2026

Heart failure, a condition in which the heart cannot pump enough blood to meet the body’s needs, is a leading driver of unplanned hospital use. More...

Clinicians often lack continuous insight into symptom changes that unfold between visits, limiting timely intervention. A new study shows that data from consumer smartwatches can flag early signs of worsening status days to weeks before urgent care is needed. The approach aims to support proactive management and reduce costly admissions.

Researchers at University Health Network (UHN; Toronto, Canada) and the University of Toronto developed and validated an artificial intelligence model that analyzes smartwatch data to estimate daily cardiopulmonary fitness. The system was designed to surface real-time changes that correlate with clinical deterioration in people living with heart failure. The work involved teams affiliated with the Ted Rogers Centre for Heart Research and Transform HF.

The method uses data streams commonly available on consumer wearables, including heart rate, physical activity, and oxygen saturation. Investigators reported that smartwatch-derived fitness estimates closely matched results from formal cardiopulmonary exercise testing performed in hospital at study entry and again at three months. Monitoring shifts in cardiopulmonary fitness over time provided a clinically relevant readout that relates to the likelihood of unplanned medical care.

In the TRUE-HF observational cohort, 217 people with heart failure were followed in free-living conditions for three months. Apple supplied 200 iPhones and Apple Watches, provided feedback on the manuscript, and collaborated with all authors to build the study-specific mobile application, while the research team independently led the study design, model development, analysis, and writing. Participants who experienced a 10% or greater decline in daily cardiopulmonary fitness had more than a three-fold increased risk of unplanned hospitalization or urgent treatment. The model’s predictions were assessed for concordance with cardiopulmonary exercise testing metrics and clinical events including declines in fitness, hospitalization, emergency visits, and intravenous furosemide administration. The findings were published in Nature Medicine.

The study underscores the need for widely available tools that can monitor heart failure outside the clinic and create an earlier window for medication adjustments or other interventions. Further research will evaluate how continuous wearable monitoring can be integrated into routine care pathways.

"The really novel thing about our study is that it captures unobtrusive, free-living data from patients in the real-world,” said Chris McIntosh, senior scientist at University Health Network and assistant professor at the University of Toronto. “We’re not only measuring how fast someone walks down a hallway in the hospital while their clinical team is standing behind them and encouraging them. We’re seeing what happens to their heart rate when they’re walking at the mall, on the street or at home."

“The findings of this study are a potential game-changer because they allow us to identify signals that would tell us a patient was in trouble before they ended up coming to the emergency room,” said Heather Ross, cardiologist at the Peter Munk Cardiac Centre and professor at the University of Toronto’s Temerty Faculty of Medicine.

Related Links
University Health Network
University of Toronto Temerty Faculty of Medicine 


Gold Member
12-Channel ECG
CM1200B
Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Vessel Sealing Instrument
ERGOseal
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image Credit: Adobe Stock

AI Platform Personalizes Support Between Visits for Cancer Survivors

Cancer survivors often manage persistent side effects after treatment, including fatigue, anxiety, uncertainty, symptoms, stress, and questions between appointments. Clinical teams need ways to maintain... Read more

Medical Imaging

view channel
Image: Visual Abstract (Andrea Farolfi et al., Journal of Nuclear Medicine, 2026. DOI: 10.2967/jnumed.126.272108)

PSMA PET/CT-Guided Biopsy Improves Detection of Significant Prostate Cancer After Nondiagnostic MRI

Prostate cancer can be difficult to detect when magnetic resonance imaging (MRI) findings are negative or inconclusive. Men with persistent clinical risk factors may still require biopsy, yet standard... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: WHX returns to Dubai Exhibition Centre, Expo City, and Dubai World Trade Centre from 5–28 January 2027 (Photo courtesy of World Health Expo)

World Health Expo to Showcase Trillion-Dollar Growth Across Pharma, Biotech, Longevity and Wellness at 2027 Edition

World Health Expo (WHX) expands with the new Pharma, Biotech, Longevity and Wellness industry sectors More than 235,000 professional visits, over 4,200 exhibitors and representatives from over... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.